Yahoo Web Search

Search results

1. • 

     Americans Are Spending the Most Money on These 25 Prescription Drugs

     Healthline· 6 days ago

     The diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....

2. • 

     Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how

     Quartz· 16 hours ago

     The millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...

3. • 

     Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs...

     Fast Company Magazine· 20 hours ago

     The San Francisco-based digital pharmacy company, which sells a variety of drugs online and direct...

4. • 

     ...Alternative Weight-loss Medications That Cost Nearly 90 Percent Less, What to Know: Price, How It...

     WWD via Yahoo Finance· 16 hours ago

     Hims & Hers Health’s compounded semaglutide medications. “Over the last year, we have grown in our...

5. • 

     'Game-changer' weight loss jab study sparks race for prescriptions

     Daily Express· 6 days ago

     The discovery that weight loss jabs could be the biggest heart health breakthrough since statins has...

6. • 

     People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later

     Healthline via AOL· 7 days ago

     In a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10%...

7. • 

     All About Ozempic and the Next Generation of Obesity Drugs

     New York Times· 2 days ago

     Here’s a primer on Ozempic and other popular drugs being widely used for diabetes and weight loss....

8. • 

     Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies

     Zacks via Yahoo Finance· 7 days ago

     Eli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...

9. • 

     No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

     Benzinga via Yahoo Finance· 7 days ago

     The agency had warned of limited supply for the 1 mg injection pen from late May to mid-June and the...

10. • 

      Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com

      Investing.com· 6 days ago

      Biora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...